Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Carmell Corporation (CTCX)

Carmell Corporation (CTCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Carmell Corporation 2403 Sidney Street Suite 300 Pittsburgh PA 15203 USA

www.carmellcorp.com Employees: 9 P: 919-313-9633

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Carmell Corporation is a commercial stage regenerative care company with a focus on using human biomaterials for aesthetics and skin healing. The company's pipeline includes cosmetic and dental products under development. Carmell Corporation, formerly known as Carmell Therapeutics Corporation, is based in PITTSBURGH.

Key Statistics

Overview:

Market Capitalization, $K 4,125
Enterprise Value, $K 1,215
Shares Outstanding, K 20,905
Annual Sales, $ 0 K
Annual Net Income, $ -15,450 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -2,880 K
EBIT, $ -970 K
EBITDA, $ -810 K
60-Month Beta 0.51
% of Insider Shareholders 29.00%
% of Institutional Shareholders 24.22%
Float, K 14,843
% Float 71.00%
Short Volume Ratio 0.70

Growth:

1-Year Return -93.45%
3-Year Return -97.96%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/14/24
Next Earnings Date 04/07/25
Earnings Per Share ttm -0.46
EPS Growth vs. Prev Qtr 12.50%
EPS Growth vs. Prev Year 77.42%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CTCX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -217.50%
Return-on-Assets % -50.22%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 132.21
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.19
Interest Coverage -18.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar